Longeveron stock rallies 85% on Alzheimer's presentation (update) [Seeking Alpha]
Longeveron Inc. - Class A Common stock (LGVN)
Company Research
Source: Seeking Alpha
study for its therapy Lomecel-B in the treatment of mild Alzheimer's disease at the Alzheimer's Association International Conference in July. Longeveron plans to make an oral presentation on the study on July 28 and a poster presentation on July 30. The conference will be held in Philadelphia from July 28 through Aug. 1. Topline results from the study were announced in October, with additional data released in December. Recommended For You More Trending News Recommended For You More Trending News About LGVN Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LGVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LGVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LGVN alerts
High impacting Longeveron Inc. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
LGVN
News
- Longeveron Inc. (NASDAQ: LGVN) had its price target raised by analysts at HC Wainwright from $6.00 to $12.00. They now have a "buy" rating on the stock.MarketBeat
- Longeveron to Present at the Planet MicroCap Showcase [Yahoo! Finance]Yahoo! Finance
- Longeveron to Present at the Planet MicroCap ShowcaseGlobeNewswire
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering [Yahoo! Finance]Yahoo! Finance
- Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public OfferingGlobeNewswire
LGVN
Earnings
- 11/10/23 - Miss
LGVN
Sec Filings
- 4/25/24 - Form D
- 4/18/24 - Form 8-K
- 4/18/24 - Form EFFECT
- LGVN's page on the SEC website